31 10, 2022

Actinium Pharmaceuticals (ATNM) Jumps 39% After Trial Results – Here’s What Investors Should Do…

2022-11-16T13:34:11+00:00October 31st, 2022|Categories: Feature: Stock Market Investing, Featured: News, Hot Stocks|Tags: , , |0 Comments

Actinium Pharmaceuticals (ATNM) is one of the biggest movers early Monday morning. The stock is up 39% for the day after the firm released news that their latest trial results were more than optimistic. The company specializes in developing targeted therapies for cancer. Their therapies are known as antibody radiation conjugates - a special [...]

28 09, 2022

What Biogen’s Alzheimer’s Drug Results Means for the Company’s Stock

2022-11-16T13:34:16+00:00September 28th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Hot Stocks|Tags: , , , , |0 Comments

Yesterday, we discussed how Crispr stock enjoyed a short-lived jump ahead of seeking FDA approval for their gene therapy drug. But today, we’re here to talk about a drug company that has experienced a much larger spike as a result of positive news: Biogen. Biogen is engaged in discovering, developing, and delivering therapies for [...]

27 09, 2022

Crispr Stock Jumps after Seeking FDA Approval for Gene Therapy Drug…Should You Buy Now?

2022-11-16T13:34:16+00:00September 27th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Hot Stocks|Tags: , , , , |0 Comments

While many stocks are moving downwards this morning, one stock has made a nice 5% jump since the market opened - and that’s Crispr.  The company is engaged in the development of transformative drugs based on gene therapy. And news just released that they are finally on the path to seeking FDA approval for [...]

23 09, 2022

LLY is Upgraded by Analysts Ahead of New Drug…But What Does VectorVest Rate the Stock?

2022-11-16T13:34:16+00:00September 23rd, 2022|Categories: Feature: Stock Market Investing, Featured: News, Hot Stocks|Tags: , , , |0 Comments

You’d be hard-pressed to find a stock that’s shown positive growth over the past year - but Eli Lilly is one of them. The pharmaceutical developer & manufacturer has had a great year - up 35% in the last 365 days. Even looking at the bigger picture, this stock has been a high-performer. This [...]

Go to Top